Document Preview Unavailable

The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen

Geng, Nan; Su, Jingwei; Liu, Zhikun; Ding, Cuimin; Xie, Shaonan; et al.  Technology in Cancer Research & Treatment Vol. 20,  (Jan 2021).

You might have access to this document